Botanical Wellness · Pillar Guide
Terpenes & Cannabinoids: Mechanisms, the Entourage Effect & the Ultimate CBD Dosage Chart
Why does the same cannabinoid concentration in two products produce completely different effects? The answer lies in the molecular symphony of terpenes and cannabinoids — the so-called Entourage Effect. In this guide, we decode the biochemistry, the physics of vaporization, and the art of precise dosing so you can make fully informed purchasing decisions.
⚡ Executive Summary — The 5 Key Facts
- ✔Terpenes are volatile aromatic compounds (C10H16 backbone) that not only define scent and flavor but also interact directly with the endocannabinoid system and key neuroreceptors (e.g., Serotonin 5-HT1A, GABA-A).
- ✔The Entourage Effect is not a marketing myth: Publications by Russo (2011) and Morales et al. (2021) demonstrate that cannabinoids and terpenes synergistically cross the blood-brain barrier and modulate CB1/CB2 receptors — resulting in significantly lower required individual doses.
- ✔Bioavailability determines the dose: Sublingual administration of CBD oil achieves 12–35% bioavailability; inhalation (vaporization) reaches 34–56%; oral capsules only 6–19% due to first-pass metabolism in the liver.
- ✔Myrcene, Limonene, and β-Caryophyllene are the "Big Three" of botanical effects: Myrcene promotes sedation, Limonene elevates mood (D2 receptor affinity), and β-Caryophyllene acts as a phytocannabinoid, directly binding to the CB2 receptor to deliver anti-inflammatory benefits.
- ✔CBD dosing is not rocket science: The rule of thumb is 0.5–1 mg CBD per kg body weight as a starting dose, titrating up to 5 mg/kg. Our chart below provides exact milligram values for every body weight — across three tiers (low, medium, high).
1. What Are Terpenes? — Chemical Foundations & Volatility
Terpenes represent the largest and most diverse class of natural products on our planet — over 80,000 known representatives. They are built on the isoprene base unit (C5H8) and are produced in plant metabolism via two biosynthetic pathways: the mevalonate pathway (cytosolic) and the MEP/DOXP pathway (plastidial). In the cannabis plant, terpenes are synthesized in trichomes — the microscopic resin glands found on the flowers — where they are stored alongside cannabinoids in so-called sessile and stalked glands.
The critical factor for practical application is volatility: terpenes exhibit vapor pressure curves that begin to activate even at room temperature. Monoterpenes (e.g., Limonene, boiling point ~176 °C) evaporate faster than sesquiterpenes (e.g., β-Caryophyllene, boiling point ~270 °C). When vaporizing CBD flowers, this means: a precisely calibrated vaporizer with temperature display in the range of 150–210 °C enables the selective release of desired terpene profiles without combusting cannabinoids. Above 230 °C, terpenes begin to degrade and form undesirable carbonyl compounds (e.g., benzene derivatives).
| Terpene / Cannabinoid | Boiling Point (°C) | Optimal Vaporization | Primary Effect | Biochemical Mechanism |
|---|---|---|---|---|
| β-Myrcene | 166–168 | 150–170 °C | Sedating, muscle relaxant | Increases CB1 receptor density; GABAA potentiation |
| D-Limonene | 176–177 | 150–176 °C | Mood-elevating, anxiolytic | 5-HT1A serotonin agonist; increases adrenaline |
| β-Caryophyllene | 266–270 | 130–200 °C | Anti-inflammatory, analgesic | Selective CB2 receptor agonist |
| Linalool | 198–199 | 180–199 °C | Calming, anxiolytic | AChE inhibition; GABA modulation |
| α-Pinene | 155–156 | 150–156 °C | Concentration-enhancing | AChE inhibitor; anti-inflammatory (COX-2) |
| Terpinolene | 186–188 | 180–188 °C | Activating, sedating (paradoxical) | Modulates GABAA receptors in a dose-dependent manner |
| CBD | 160–180 (Decarb.) | 160–180 °C | Anxiolytic, anticonvulsant | Allosteric CB1 modulator; TRPV1 agonist |
| CBG | 120–130 (Decarb.) | 150–170 °C | Neuroprotective, focus-enhancing | CB1/CB2 partial agonist; α2-Adrenoceptor |
2. Myrcene, Limonene & Caryophyllene — The "Big Three" in Detail
2.1 β-Myrcene — The Quintessential "Entourage Terpene"
β-Myrcene (C10H16) is the dominant monoterpene in most cannabis strains, accounting for 20–65% of the total terpene profile. It is also found in mangoes, hops, and Muscat grapevines — hence the old folk wisdom that mangoes can amplify the "high." The biochemistry behind this: myrcene increases the permeability of the blood-brain barrier and upregulates CB1 receptor expression, thereby amplifying cannabis-mimetic effects. Studies published in the Journal of Ethnopharmacology (Galdino et al., 2012) confirmed a 160% increase in barbiturate-induced sleep duration upon myrcene exposure.
2.2 D-Limonene — The Neurotransmitter Booster
Limonene (C10H16) is the second most abundant monoterpene and boasts a remarkably high bioavailability exceeding 70% when inhaled. It crosses the blood-brain barrier within seconds and binds to the 5-HT1A serotonin receptor, producing anxiolytic effects comparable to the mechanism of action of buspirone. Simultaneously, it stimulates adrenaline production (via glutamatergic pathways), which — paradoxically — counteracts the calming effect and produces the characteristic energetic, uplifting euphoria associated with Limonene-dominant chemotypes.
2.3 β-Caryophyllene — The Phytocannabinoid Terpene
β-Caryophyllene (C15H24) holds a unique position in the botanical pharmacopeia: it is the only terpene to date that has been conclusively identified as a selective agonist of the CB2 receptor — the primary mediator of anti-inflammatory and analgesic signaling in the endocannabinoid system. Unlike its sesquiterpene counterparts, its relatively low boiling point range for practical vaporization (130–200 °C) makes it highly effective in convection-based vaporizers and sub-ohm devices. Research published in the Proceedings of the National Academy of Sciences (Gertsch et al., 2008) was instrumental in classifying β-Caryophyllene as a dietary cannabinoid. Its anti-inflammatory profile operates via suppression of NF-κB signaling pathways, making it particularly relevant for users seeking pain relief without psychoactive overload.
3. The Entourage Effect — Synergistic Pharmacology Explained
The concept of the Entourage Effect, first formally proposed by Ethan B. Russo in 2011, describes the synergistic interaction between cannabinoids, terpenes, flavonoids, and other phytochemicals. Rather than acting as independent agents, these compounds potentiate each other's bioactivity through multiple mechanisms:
- Blood-brain barrier modulation: Terpenes such as myrcene and limonene increase the permeability of the blood-brain barrier, accelerating the transport of cannabinoids into central nervous system tissue. This results in faster onset and lower required doses.
- Receptor cross-talk: While cannabinoids primarily target CB1 and CB2 receptors, terpenes engage complementary receptor systems — including serotonergic (5-HT1A), GABAergic (GABAA), adrenergic, and TRPV1 pathways — creating a multi-system therapeutic effect.
- Receptor density upregulation: Myrcene specifically has been shown to increase the expression density of CB1 receptors in neural tissue, effectively "priming" the endocannabinoid system for enhanced cannabinoid sensitivity.